SCHEMBL2653618

SCHEMBL2653618

CCCCC(O)c1ccccc1C(=O)OC

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARG P37231 3/20 0.49
CYP1A2 P05177 1/20 0.49
CYP2C19 P33261 1/20 0.49
SMN1; SMN2 Q16637 1/20 0.49
ALDH1A1 P00352 4/20 0.49
CYP3A4 P08684 2/20 0.49
CA2 P00918 1/20 0.49
TSHR P16473 5/20 0.46
TDP1 Q9NUW8 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
LMNA P02545 3/20 0.46
TP53 P04637 1/20 0.45
MAPK1 P28482 1/20 0.45
HSD17B10 Q99714 2/20 0.45
CFTR P13569 1/20 0.45
KMT2A Q03164 2/20 0.44
ALOX12 P18054 1/20 0.44
KDM4E B2RXH2 2/20 0.44
POLB P06746 1/20 0.44
ATM Q13315 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2655007 0.94 PPARG (0.56) PPARGCYP1A2CYP2C19SMN1; SMN2ALDH1A1
SCHEMBL14763612 0.86 KDM4E (0.50) ALDH1A1CA2TSHRLMNAHSD17B10
SCHEMBL9030811 0.85 LMNA (0.50) ALDH1A1CA2TSHRLMNAHSD17B10
SCHEMBL30768207 0.85 CYP1A2 (0.47) CYP1A2CYP2C19SMN1; SMN2ALDH1A1CYP3A4
SCHEMBL6472205 0.82 CYP1A2 (0.45) CYP1A2CYP2C19SMN1; SMN2ALDH1A1CYP3A4
SCHEMBL23521275 0.82 KMT2A (0.50) PPARGALDH1A1CYP3A4CA2TSHR
SCHEMBL29360777 0.82 KMT2A (0.50) PPARGALDH1A1CYP3A4CA2TSHR
SCHEMBL29869129 0.82 KMT2A (0.50) PPARGALDH1A1CYP3A4CA2TSHR
SCHEMBL23521291 0.82 KMT2A (0.50) PPARGALDH1A1CYP3A4CA2TSHR
SCHEMBL1935639 0.82 KMT2A (0.50) PPARGALDH1A1CYP3A4CA2TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1758853-A1 GLUCAGON RECEPTOR ANTAGONISTS, PREPARATION AND THERAPEUTIC USES ELI LILLY AND COMPANY (US) 2007-03-07 EP disclosed
WO-2005123668-A1 GLUCAGON RECEPTOR ANTAGONISTS, PREPARATION AND THERAPEUTIC USES ELI LILLY AND COMPANY (US) 2005-12-29 WO disclosed